{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
<< Return to Main Site
Avera
  • Sign In
  • Events & Live Courses
  • On-Demand Courses
  • Conferences
  • Calendar
  • MARCH
  • CE Planner Resources
  • FAQs
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Avera employees:  Click "Sign in with Use My Avera Login" (Avera network email and password).  All others, click sign in with your CloudCME (Avera CE Portal) account. 

NOTE:  If this is the first time using your Avera network email and password to sign in, you will be directed to your Profile page.  Your profile must be completed and/or updated before doing anything in the Portal including registering for events, completing evaluations, etc.

If you continue to have problems, contact [email protected] for help.

Click here for FAQs.

Use My Avera Login
Login with my CloudCME™ account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AD
  • ADN
  • APRN
  • APRN
  • ARRT
  • ASN
  • ASRT
  • ASW
  • AT
  • ATC
  • BA
  • BAN
  • BM BCh
  • BM BS
  • BM ChB
  • BP
  • Bpharm
  • BS
  • BScPH
  • BSN
  • BSPh
  • BSPT
  • BSRT
  • BSW
  • CCT
  • CDM
  • Chaplain
  • CMA
  • CNA
  • CNL
  • CNM
  • CNP
  • CNS
  • CPhT
  • CRNA
  • CRNP
  • CST
  • CSW-PIP
  • CVT
  • DC
  • DDS
  • DMD
  • DNE
  • DNP
  • DNSc
  • DO
  • DP
  • DPharm
  • DPM
  • DPN
  • DPT
  • DSW
  • EMT
  • JD
  • LCSW
  • LMFT
  • LPC
  • LPN
  • LRCPE
  • LRCPSG
  • LRCSE
  • LVN
  • MA
  • MB BCH
  • MB Bchir
  • MB BS
  • MB ChB
  • MBA
  • MBBS, MPH
  • MD
  • MDCM
  • MDiv
  • MLS
  • MLT
  • Mmed
  • MMilMed
  • MPh
  • MPH
  • Mpharm
  • MPT
  • MS
  • MScPH
  • MScPharm
  • MSN
  • MSN - Certified Nurse Midwife
  • MSN - Certified registered nurse anesthetist
  • MSN - Clinical Nurse Leader
  • MSN - Clinical Nurse Specialist
  • MSN - Nurse Practitioner
  • MSPH
  • MSPharm
  • MSSA
  • MSW
  • ND
  • None
  • NP
  • OD
  • Other
  • OTR
  • PA
  • Paramedic
  • PD
  • Ph D
  • Pharm
  • PharmD
  • PharmDc
  • PhD SW
  • PsyD
  • PT
  • PTA
  • RCES
  • RCIS
  • RCP
  • RD
  • RDCS
  • Resident
  • RN
  • RPh
  • RT
  • RVT
  • Student
  • SW
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

2025 Sequencing Tumor Board - 12/25/2025

  • Overview
  • Speakers
  • Schedule / Brochure
Add to Calendar 2025 Sequencing Tumor Board - 12/25/2025 12/25/2025 7:00:00 AM 12/25/2025 8:00:00 AM America/Chicago For More Details: https://avera.cloud-cme.com/course/courseoverview?EID=21438 Description: This case conference offers a multidisciplinary approach to review cases for somatic tumor results as well as other biomarkers and patient specific factors are considered and discussed to find treatment options for patients with cancer that have limited treatment options. The cases presented are referred by the treating oncologist or surgeon once the results for their next-generation sequencing tests f... false MM/DD/YYYY


Date & Location
Thursday, December 25, 2025, 7:00 AM - 8:00 AM, Sioux Falls, SD

Registration
For additional information, contact [email protected]

Overview
This case conference offers a multidisciplinary approach to review cases for somatic tumor results as well as other biomarkers and patient specific factors are considered and discussed to find treatment options for patients with cancer that have limited treatment options. The cases presented are referred by the treating oncologist or surgeon once the results for their next-generation sequencing tests from their tumor are returned. The multidisciplinary review includes the oncologists, surgeons and additional experts in oncology, pharmacology, genetics and clinical trials to discuss the best treatment options for individual patients based on the genomic alterations present in their cancer along with other questions about diagnostics, prognostic implications, potential clinical trials, and best standard of care options.

Target Audience
Specialties - Oncology
Professions - Pharmacist, Pharmacy Technician, Physician

Objectives
 Bibliography

Disclaimer:

All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner.

 

ADA Statement:

ADA accommodations will be made in accordance with the law.  If you require ADA accommodations, please indicate what your needs are at the time of registration.  We cannot ensure the availability of appropriate accommodations without prior notification.


  1. Integrate a multidisciplinary approach into the development of plan of care
  2. Identify social determinants that affect patient care for oncology patients
  3. Discuss and analyze patient cases with the healthcare team
  4. Develop strategies and a team approach to prevent complications from therapies

Accreditation

 

In support of improving patient care, Avera is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

 

Credit Designations:

 

This activity was planned by and for the healthcare team, and learners will receive 1.0 IPCE credits for learning and change. 

 

 

 

Medicine CME:  Avera designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.  It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

 

 

 

 

 

Pharmacy CE: Avera designates this activity for 1.00 ACPE contact hour(s). Pharmacists and pharmacy technicians should claim only the
credit commensurate with the extent of their participation in the activity. Credit will be uploaded to the NABP CPE Monitor® within 30
days after the activity completion. Per ACPE rules, Avera does not have access nor the ability to upload credits requested after the
evaluation closes. It is the responsibility of the pharmacist or pharmacy technician to provide the correct information (NABP ID and DOB
(MMDD)) to receive credit.

 

 



Keywords: ABSACPEIPCEMOC



Mitigation of Relevant Financial Relationships


Avera adheres to the Joint Accreditation’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Faculty Photos
Tobias Meissner, PhD, Researcher
Cancer Genomics Manager
Avera Cancer Institute
Content Expert - Committee Member
Faculty Photos
Benjamin Solomon, MD, Physician
Physician
Avera Medical Group Oncology & Hematology Sioux Falls
Content Expert - Committee Member
Nothing to disclose
Rachel Elsey, PharmD, Pharmacist
Cancer Genomics Pharmacist Coordinator
Avera
Faculty, Lead Planner
Hannah Koble
Grant Writer
Avera Cancer Institute
Proxy

Sort by: Date Name

Date Empty Column Title
12/25/2025 7:00:00 AM 2025 Sequencing Tumor Board - 12/25/2025 12/25/2025 7:00:00 AM 12/25/2025 8:00:00 AM 11 False MM/DD/YYYY 2025 Sequencing Tumor Board - 12/25/2025

This case conference offers a multidisciplinary approach to review cases for somatic tumor results as well as other biomarkers and patient specific factors are considered and discussed to find treatment options for patients with cancer that have limited treatment options. The cases presented are referred by the treating oncologist or surgeon once the results for their next-generation sequencing tests from their tumor are returned. The multidisciplinary review includes the oncologists, surgeons and additional experts in oncology, pharmacology, genetics and clinical trials to discuss the best treatment options for individual patients based on the genomic alterations present in their cancer along with other questions about diagnostics, prognostic implications, potential clinical trials, and best standard of care options.
Specialties: Oncology

Disclosure

3900 Avera Drive
Sioux Falls, SD 57108
©2023 Avera Continuing Education
Privacy Policy

Powered By CloudCME

Jointly Accredited